Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medroxyprogesterone acetate versus GnRH antagonist in oocyte-donation ICSI
IRCT20081007001306N10Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Aug 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of medroxyprogesterone acetate in female infertility (2 arms), sponsored by Guilan University of Medical Sciences. Primary endpoints: Fertility success, Transvaginal ultrasound outcome and 1 more. Started Aug 2019; status: completed.
02
Drugs
medroxyprogesterone acetate
03
Conditions
female infertility
Beyond the preview
Go deeper on IRCT20081007001306N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20081007001306N10.